High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas

Despite a favourable prognosis, pilocytic astrocytomas may exhibit signs of malignancy on various neuroimaging modalities. This retrospective analysis was conducted to determine whether scintigraphic features of malignancy are also found on single-photon emission tomography (SPET) using L-3-[^sup 12...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nuclear medicine and molecular imaging 2001-03, Vol.28 (3), p.273
Hauptverfasser: Weckesser, Matthias, Matheja, Peter, Rickert, Christian H, Sträter, Ronald, Palkovic, Stefan, Löttgen, Jan, Kurlemann, Gerd, Paulus, Werner, Wassmann, Hansdetlef, Schober, Otmar
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 273
container_title European journal of nuclear medicine and molecular imaging
container_volume 28
creator Weckesser, Matthias
Matheja, Peter
Rickert, Christian H
Sträter, Ronald
Palkovic, Stefan
Löttgen, Jan
Kurlemann, Gerd
Paulus, Werner
Wassmann, Hansdetlef
Schober, Otmar
description Despite a favourable prognosis, pilocytic astrocytomas may exhibit signs of malignancy on various neuroimaging modalities. This retrospective analysis was conducted to determine whether scintigraphic features of malignancy are also found on single-photon emission tomography (SPET) using L-3-[^sup 123^I]iodo-α-methyl tyrosine (IMT) as a tracer. Twenty patients with pilocytic astrocytomas were retrospectively selected from a large series of patients referred for the evaluation of primary or recurrent brain tumours. IMT SPET was performed in 16 patients, positron emission tomography (PET) using 2-[^sup 18^F]fluoro-2-deoxy-D-glucose (FDG) was available in 10 of the patients and SPET using technetium-99m tetrofosmin or thallium-201 had been performed in 11. Image analysis was performed using standard protocols to determine how many patients exceeded the respective thresholds of malignancy. Features of malignancy were found in 7/16 IMT SPET studies, in 7/10 FDG PET studies and in 7/11 of the residual SPET investigations. A significant correlation of tumour size and IMT uptake in primary pilocytic astrocytomas indicated partial volume effects to partly account for the differential uptake behaviour (n=10, r=0.87, P
doi_str_mv 10.1007/s002590000462
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1026705346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2709436881</sourcerecordid><originalsourceid>FETCH-proquest_journals_10267053463</originalsourceid><addsrcrecordid>eNqNijsLwjAYRYMoWB-je8A5-iV9z6JUEFzcSimhpja1bWqTDv33VhBnz3IP3IPQhsKOAvh7DcDcEEYcj02QRT0aEh-CcPpzH-ZooXUJQAMWhBa6RvJR4L41_CmwyvGF2CSmzD4nUt0ViXnVFjwhtTDFUGEzdErLRmDZ4FZWKhuMzDDXpvuoqrleoVnOKy3W312i7el4O0Sk7dSrF9qkpeq7ZrxSCszzwbUdz_6vegN290Oo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1026705346</pqid></control><display><type>article</type><title>High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas</title><source>Springer Nature - Complete Springer Journals</source><creator>Weckesser, Matthias ; Matheja, Peter ; Rickert, Christian H ; Sträter, Ronald ; Palkovic, Stefan ; Löttgen, Jan ; Kurlemann, Gerd ; Paulus, Werner ; Wassmann, Hansdetlef ; Schober, Otmar</creator><creatorcontrib>Weckesser, Matthias ; Matheja, Peter ; Rickert, Christian H ; Sträter, Ronald ; Palkovic, Stefan ; Löttgen, Jan ; Kurlemann, Gerd ; Paulus, Werner ; Wassmann, Hansdetlef ; Schober, Otmar</creatorcontrib><description>Despite a favourable prognosis, pilocytic astrocytomas may exhibit signs of malignancy on various neuroimaging modalities. This retrospective analysis was conducted to determine whether scintigraphic features of malignancy are also found on single-photon emission tomography (SPET) using L-3-[^sup 123^I]iodo-α-methyl tyrosine (IMT) as a tracer. Twenty patients with pilocytic astrocytomas were retrospectively selected from a large series of patients referred for the evaluation of primary or recurrent brain tumours. IMT SPET was performed in 16 patients, positron emission tomography (PET) using 2-[^sup 18^F]fluoro-2-deoxy-D-glucose (FDG) was available in 10 of the patients and SPET using technetium-99m tetrofosmin or thallium-201 had been performed in 11. Image analysis was performed using standard protocols to determine how many patients exceeded the respective thresholds of malignancy. Features of malignancy were found in 7/16 IMT SPET studies, in 7/10 FDG PET studies and in 7/11 of the residual SPET investigations. A significant correlation of tumour size and IMT uptake in primary pilocytic astrocytomas indicated partial volume effects to partly account for the differential uptake behaviour (n=10, r=0.87, P&lt;0.05). Differences in IMT uptake in primaries (1.7±0.6, n=10) and in recurrent tumours (2.3±0.7, n=6) did not attain statistical significance. IMT SPET results indicative of malignancy are regularly found in pilocytic astrocytomas, despite their good prognosis. No uptake may be detected in largely cystic or in small tumours.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s002590000462</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><ispartof>European journal of nuclear medicine and molecular imaging, 2001-03, Vol.28 (3), p.273</ispartof><rights>Springer-Verlag 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Weckesser, Matthias</creatorcontrib><creatorcontrib>Matheja, Peter</creatorcontrib><creatorcontrib>Rickert, Christian H</creatorcontrib><creatorcontrib>Sträter, Ronald</creatorcontrib><creatorcontrib>Palkovic, Stefan</creatorcontrib><creatorcontrib>Löttgen, Jan</creatorcontrib><creatorcontrib>Kurlemann, Gerd</creatorcontrib><creatorcontrib>Paulus, Werner</creatorcontrib><creatorcontrib>Wassmann, Hansdetlef</creatorcontrib><creatorcontrib>Schober, Otmar</creatorcontrib><title>High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas</title><title>European journal of nuclear medicine and molecular imaging</title><description>Despite a favourable prognosis, pilocytic astrocytomas may exhibit signs of malignancy on various neuroimaging modalities. This retrospective analysis was conducted to determine whether scintigraphic features of malignancy are also found on single-photon emission tomography (SPET) using L-3-[^sup 123^I]iodo-α-methyl tyrosine (IMT) as a tracer. Twenty patients with pilocytic astrocytomas were retrospectively selected from a large series of patients referred for the evaluation of primary or recurrent brain tumours. IMT SPET was performed in 16 patients, positron emission tomography (PET) using 2-[^sup 18^F]fluoro-2-deoxy-D-glucose (FDG) was available in 10 of the patients and SPET using technetium-99m tetrofosmin or thallium-201 had been performed in 11. Image analysis was performed using standard protocols to determine how many patients exceeded the respective thresholds of malignancy. Features of malignancy were found in 7/16 IMT SPET studies, in 7/10 FDG PET studies and in 7/11 of the residual SPET investigations. A significant correlation of tumour size and IMT uptake in primary pilocytic astrocytomas indicated partial volume effects to partly account for the differential uptake behaviour (n=10, r=0.87, P&lt;0.05). Differences in IMT uptake in primaries (1.7±0.6, n=10) and in recurrent tumours (2.3±0.7, n=6) did not attain statistical significance. IMT SPET results indicative of malignancy are regularly found in pilocytic astrocytomas, despite their good prognosis. No uptake may be detected in largely cystic or in small tumours.[PUBLICATION ABSTRACT]</description><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNijsLwjAYRYMoWB-je8A5-iV9z6JUEFzcSimhpja1bWqTDv33VhBnz3IP3IPQhsKOAvh7DcDcEEYcj02QRT0aEh-CcPpzH-ZooXUJQAMWhBa6RvJR4L41_CmwyvGF2CSmzD4nUt0ViXnVFjwhtTDFUGEzdErLRmDZ4FZWKhuMzDDXpvuoqrleoVnOKy3W312i7el4O0Sk7dSrF9qkpeq7ZrxSCszzwbUdz_6vegN290Oo</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>Weckesser, Matthias</creator><creator>Matheja, Peter</creator><creator>Rickert, Christian H</creator><creator>Sträter, Ronald</creator><creator>Palkovic, Stefan</creator><creator>Löttgen, Jan</creator><creator>Kurlemann, Gerd</creator><creator>Paulus, Werner</creator><creator>Wassmann, Hansdetlef</creator><creator>Schober, Otmar</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20010301</creationdate><title>High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas</title><author>Weckesser, Matthias ; Matheja, Peter ; Rickert, Christian H ; Sträter, Ronald ; Palkovic, Stefan ; Löttgen, Jan ; Kurlemann, Gerd ; Paulus, Werner ; Wassmann, Hansdetlef ; Schober, Otmar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_10267053463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weckesser, Matthias</creatorcontrib><creatorcontrib>Matheja, Peter</creatorcontrib><creatorcontrib>Rickert, Christian H</creatorcontrib><creatorcontrib>Sträter, Ronald</creatorcontrib><creatorcontrib>Palkovic, Stefan</creatorcontrib><creatorcontrib>Löttgen, Jan</creatorcontrib><creatorcontrib>Kurlemann, Gerd</creatorcontrib><creatorcontrib>Paulus, Werner</creatorcontrib><creatorcontrib>Wassmann, Hansdetlef</creatorcontrib><creatorcontrib>Schober, Otmar</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weckesser, Matthias</au><au>Matheja, Peter</au><au>Rickert, Christian H</au><au>Sträter, Ronald</au><au>Palkovic, Stefan</au><au>Löttgen, Jan</au><au>Kurlemann, Gerd</au><au>Paulus, Werner</au><au>Wassmann, Hansdetlef</au><au>Schober, Otmar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><date>2001-03-01</date><risdate>2001</risdate><volume>28</volume><issue>3</issue><spage>273</spage><pages>273-</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Despite a favourable prognosis, pilocytic astrocytomas may exhibit signs of malignancy on various neuroimaging modalities. This retrospective analysis was conducted to determine whether scintigraphic features of malignancy are also found on single-photon emission tomography (SPET) using L-3-[^sup 123^I]iodo-α-methyl tyrosine (IMT) as a tracer. Twenty patients with pilocytic astrocytomas were retrospectively selected from a large series of patients referred for the evaluation of primary or recurrent brain tumours. IMT SPET was performed in 16 patients, positron emission tomography (PET) using 2-[^sup 18^F]fluoro-2-deoxy-D-glucose (FDG) was available in 10 of the patients and SPET using technetium-99m tetrofosmin or thallium-201 had been performed in 11. Image analysis was performed using standard protocols to determine how many patients exceeded the respective thresholds of malignancy. Features of malignancy were found in 7/16 IMT SPET studies, in 7/10 FDG PET studies and in 7/11 of the residual SPET investigations. A significant correlation of tumour size and IMT uptake in primary pilocytic astrocytomas indicated partial volume effects to partly account for the differential uptake behaviour (n=10, r=0.87, P&lt;0.05). Differences in IMT uptake in primaries (1.7±0.6, n=10) and in recurrent tumours (2.3±0.7, n=6) did not attain statistical significance. IMT SPET results indicative of malignancy are regularly found in pilocytic astrocytomas, despite their good prognosis. No uptake may be detected in largely cystic or in small tumours.[PUBLICATION ABSTRACT]</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s002590000462</doi></addata></record>
fulltext fulltext
identifier ISSN: 1619-7070
ispartof European journal of nuclear medicine and molecular imaging, 2001-03, Vol.28 (3), p.273
issn 1619-7070
1619-7089
language eng
recordid cdi_proquest_journals_1026705346
source Springer Nature - Complete Springer Journals
title High uptake of L-3-[123I]iodo-[alpha]-methyl tyrosine in pilocytic astrocytomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A47%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20uptake%20of%20L-3-%5B123I%5Diodo-%5Balpha%5D-methyl%20tyrosine%20in%20pilocytic%20astrocytomas&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Weckesser,%20Matthias&rft.date=2001-03-01&rft.volume=28&rft.issue=3&rft.spage=273&rft.pages=273-&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s002590000462&rft_dat=%3Cproquest%3E2709436881%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1026705346&rft_id=info:pmid/&rfr_iscdi=true